PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
-5.07%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$4.82B
AUM Growth
-$690M
(-13%)
Cap. Flow
-$106M
Cap. Flow
% of AUM
-2.2%
Top 10 Holdings %
Top 10 Hldgs %
17.51%
Holding
1,585
New
253
Increased
697
Reduced
410
Closed
140
Top Buys
| 1 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
+$41.8M |
| 2 |
Caterpillar
CAT
|
+$24.9M |
| 3 |
Analog Devices
ADI
|
+$22.8M |
| 4 |
CSX Corp
CSX
|
+$18.7M |
| 5 |
OXLC
Oxford Lane Capital
OXLC
|
+$14.5M |
Top Sells
| 1 |
Baidu
BIDU
|
+$23.1M |
| 2 |
BlackRock Resources & Commodities Strategy Trust
BCX
|
+$22.3M |
| 3 |
MXIM
Maxim Integrated Products
MXIM
|
+$21.2M |
| 4 |
NFJ
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
|
+$21.1M |
| 5 |
Invesco Senior Income Trust
VVR
|
+$19.6M |
Sector Composition
| 1 | Technology | 27.88% |
| 2 | Consumer Discretionary | 25.52% |
| 3 | Communication Services | 11.6% |
| 4 | Industrials | 6.01% |
| 5 | Financials | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Bristol-Myers Squibb
BMY
$96.1B
| $30K | ﹤0.01% |
522
+117
| +29% | +$6.72K |
|
1177
Estee Lauder
EL
$31.4B
| $30K | ﹤0.01% |
102
-18
| -15% | -$5.29K |
|
1178
Finance of America Companies
FOA
$283M
| $30K | ﹤0.01% |
617
-483
| -44% | -$23.5K |
|
1179
iShares ESG MSCI EM Leaders ETF
LDEM
$31.8M
| $30K | ﹤0.01% |
+504
| New | +$30K |
|
1180
Madrigal Pharmaceuticals
MDGL
$9.9B
| $30K | ﹤0.01% |
380
| – | – |
|
1181
Nautilus Biotechnolgy
NAUT
$88.5M
| $30K | ﹤0.01% |
4,964
+210
| +4% | +$1.27K |
|
1182
Nurix Therapeutics
NRIX
$694M
| $30K | ﹤0.01% |
1,015
+5
| +0.5% | +$148 |
|
1183
OppFi
OPFI
$297M
| $30K | ﹤0.01% |
3,861
-4,145
| -52% | -$32.2K |
|
1184
Vaxcyte
PCVX
$4.27B
| $30K | ﹤0.01% |
1,195
+25
| +2% | +$628 |
|
1185
Sempra
SRE
$52.8B
| $30K | ﹤0.01% |
480
+170
| +55% | +$10.6K |
|
|
BLUE
1186
DELISTED
bluebird bio
BLUE
| $29K | ﹤0.01% |
119
| – | – |
|
1187
Interactive Brokers
IBKR
$27.9B
| $29K | ﹤0.01% |
+1,920
| New | +$29K |
|
1188
Lithia Motors
LAD
$8.78B
| $29K | ﹤0.01% |
92
+8
| +10% | +$2.52K |
|
1189
MacroGenics
MGNX
$109M
| $29K | ﹤0.01% |
1,400
+35
| +3% | +$725 |
|
1190
Morgan Stanley
MS
$245B
| $29K | ﹤0.01% |
300
+50
| +20% | +$4.83K |
|
1191
Sangamo Therapeutics
SGMO
$160M
| $29K | ﹤0.01% |
3,325
+50
| +2% | +$436 |
|
|
BGRY
1192
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $29K | ﹤0.01% |
4,231
-2,577
| -38% | -$17.7K |
|
1193
Arcturus Therapeutics
ARCT
$480M
| $28K | ﹤0.01% |
605
+5
| +0.8% | +$231 |
|
1194
Axsome Therapeutics
AXSM
$6.29B
| $28K | ﹤0.01% |
865
+10
| +1% | +$324 |
|
1195
Coherus Oncology, Inc. Common Stock
CHRS
$156M
| $28K | ﹤0.01% |
1,750
+25
| +1% | +$400 |
|
1196
Kura Oncology
KURA
$726M
| $28K | ﹤0.01% |
1,515
+5
| +0.3% | +$92 |
|
1197
TJX Companies
TJX
$155B
| $28K | ﹤0.01% |
438
-2
| -0.5% | -$128 |
|
1198
Tradeweb Markets
TW
$25.3B
| $28K | ﹤0.01% |
+347
| New | +$28K |
|
1199
Y-mAbs Therapeutics
YMAB
$390M
| $28K | ﹤0.01% |
995
+5
| +0.5% | +$141 |
|
1200
Air Products & Chemicals
APD
$64B
| $27K | ﹤0.01% |
108
+23
| +27% | +$5.75K |
|